ARCT-154, also known as VBC-COV19-154 in Vietnam, is a COVID-19 vaccine candidate developed by Arcturus Therapeutics.
Read more in the app
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
AstraZeneca's COVID Vaccine Withdrawn – But Let's Untangle The Facts From The Fiction
A New Way to Inspire People to Get a COVID Vaccine
Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far
Researchers Who Made COVID Vaccine Possible Awarded Nobel Prize
FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant
New Research Uncovers Potential Explanation for COVID Vaccine Blood Clot Connection
AstraZeneca’s Covid Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows
Study examines heart inflammation after COVID vaccine
After Long Delay, Moderna Pays N.I.H. for Covid Vaccine Technique
Kizzmekia Corbett Unlocked the Science of the Covid Vaccine
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
InnovationRx: Health System Quality; Plus, A Yearly Covid Vaccine
Key Partner in Covax Will Stop Giving Free Vaccines to Middle-Income Nations
New Research: Your Choice of COVID Vaccine Can Increase Your Risk of Myocarditis
Which COVID vaccine you get can impact myocarditis risk
Intranasal COVID vaccine that works against variants in animals
Cancer vaccine may be ready by 2030, say COVID vaccine makers
The World's First Needle-Free COVID Vaccine Just Got Approved in China
Three Covid Vaccine Doses Better Than Two Against Omicron Infections, New Study Reinforces